Premium
A 24‐week pegylated interferon alpha‐2b versus a 12‐week pegylated interferon alpha‐2b alone or with ribavirin for patients with acute hepatitis C
Author(s) -
Dai ChiaYen,
Chuang WanLong,
Yu MingLung
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27096
Subject(s) - ribavirin , medicine , pegylated interferon , alpha interferon , alpha (finance) , hepatitis c , gastroenterology , pharmacology , interferon , chronic hepatitis , virology , surgery , virus , construct validity , patient satisfaction